Home/Filings/4/0001385508-21-000121
4//SEC Filing

Ruth Matthew R. 4

Accession 0001385508-21-000121

CIK 0001385508other

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:04 PM ET

Size

4.7 KB

Accession

0001385508-21-000121

Insider Transaction Report

Form 4
Period: 2021-08-31
Ruth Matthew R.
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2021-08-31$17.34/sh+2,000$34,68017,000 total

Issuer

OPIANT PHARMACEUTICALS, INC.

CIK 0001385508

Entity typeother

Related Parties

1
  • filerCIK 0001872022

Filing Metadata

Form type
4
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 4:04 PM ET
Size
4.7 KB